PROSPECTIVE, MULTI-CENTER PHASE III TRIAL OF TUMOR TREATING FIELDS TOGETHER WITH TEMOZOLOMIDE COMPARED TO TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

被引：0

作者：

Stupp, Roger ^{[1
,2
]}

Idbaih, Ahmed ^{[3
]}

Steinberg, David M. ^{[4
]}

Read, William ^{[5
]}

Toms, Steven ^{[6
]}

Barnett, Gene ^{[7
]}

Nicholas, Garth ^{[8
]}

Kim, Chae-Yong ^{[9
]}

Fink, Karen ^{[10
]}

Salmaggi, Andrea ^{[11
]}

Lieberman, Frank ^{[12
]}

Zhu, Jay ^{[13
]}

Taylor, Lynne ^{[14
]}

Stragliotto, Giuseppe ^{[15
]}

Hottinger, Andreas ^{[16
]}

Kirson, Eilon D. ^{[17
]}

Weinberg, Uri

Palti, Yoram ^{[17
]}

Hegi, Monika E. ^{[16
]}

Ram, Zvi ^{[18
]}

机构：

[1] Univ Hosp Zurich, Zurich, Switzerland

[2] Univ Zurich, Zurich, Switzerland

[3] Grp Hosp Pitie Salpetriere, Paris, France

[4] Tel Aviv Univ, Tel Aviv, Israel

[5] Emory Univ Hosp Midtown, Atlanta, GA USA

[6] Geisinger Med Ctr, Danville, PA 17822 USA

[7] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA

[8] Ottawa Hosp Res Inst, Ottawa, ON, Canada

[9] Seoul Natl Univ Bundang, Seoul, South Korea

[10] Baylor Charles A Sammons Canc Ctr, Dallas, TX USA

[11] Ist Natl Neurol Carlo Besta, Milan, Italy

[12] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA

[13] Mem Hermann Hosp, Houston, TX USA

[14] Tufts Med Ctr, Boston, MA USA

[15] Karolinska Hosp, Stockholm, Sweden

[16] CHU Vaudois, Lausanne, Switzerland

[17] Novocure Ltd, Haifa, Israel

[18] Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel

来源：

NEURO-ONCOLOGY | 2016年 / 18卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LTBK-01

引用

页码：1 / 1

页数：1

共 50 条

[1] PHASE III TRIAL OF TUMOR TREATING FIELDS (TTFIELDS) TOGETHER WITH TEMOZOLOMIDE (TMZ) COMPARED TO TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
Farber, Ori
Weinberg, Uri
Palti, Yoram
NEURO-ONCOLOGY, 2013, 15 : 76 - 77
[2] Phase III trial of tumor-treating fields (TTFields) together with temozolomide compared with temozolomide (TMZ) alone in patients with newly diagnosed glioblastoma multiforme (NCT00916409).
Kesari, Santosh
Taillibert, Sophie
Kanner, Andrew
Weinberg, Uri
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[3] TIME TO FUNCTIONAL AND COGNITIVE DECLINE IN A PHASE 3 TRIAL OF TUMOR TREATING FIELDS WITH TEMOZOLOMIDE VERSUS TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
Nicholas, Garth A.
Hirte, Holger
Easaw, Jacob
Muanza, Thierry
Roberge, David
Mathieu, David
Pitz, Marshall
NEURO-ONCOLOGY, 2017, 19 : 138 - 138
[4] INTERIM ANALYSIS OF THE EF-14 TRIAL: A PROSPECTIVE, MULTI-CENTER TRIAL OF NOVOTTF-100A TOGETHER WITH TEMOZOLOMIDE COMPARED TO TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GBM
Stupp, Roger
Wong, Eric
Scott, Charles
Taillibert, Sophie
Kanner, Andrew
Kesari, Santosh
Ram, Zvi
NEURO-ONCOLOGY, 2014, 16
[5] Phase III TRIDENT trial: Radiation and temozolomide plus /- tumor treating fields in newly diagnosed glioblastoma.
Shi, Wenyin
Kleinberg, Lawrence
Jeyapalan, Suriya A.
Goldlust, Samuel Aaron
Nagpal, Seema
Reardon, David A.
Combs, Stephanie E.
Roberge, David
Nishigawa, Ryo
Glas, Martin
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[6] RANDOMIZED PHASE II TRIAL OF TUMOR TREATING FIELDS PLUS RADIATION THERAPY PLUS TEMOZOLOMIDE COMPARED TO RADIATION THERAPY PLUS TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
Limon, D.
Bokstein, F.
Blumenthal, D.
Ben Harush, C.
Ram, Z.
Grossman, R.
NEURO-ONCOLOGY, 2019, 21 : 86 - 86
[7] Phase 3 TRIDENT trial: Radiation and temozolomide plus /- Tumor Treating Fields in newly diagnosed glioblastoma
Glas, M.
STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S72 - S72
[8] Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma
Zhu, Jay-Jiguang
Demireva, Petya
Kanner, Andrew A.
Pannullo, Susan
Mehdorn, Maximilian
Avgeropoulos, Nicholas
Salmaggi, Andrea
Silvani, Antonio
Goldlust, Samuel
David, Carlos
Benouaich-Amiel, Alexandra
Ram, Zvi
JOURNAL OF NEURO-ONCOLOGY, 2017, 135 (03) : 545 - 552
[9] Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma
Jay-Jiguang Zhu
Petya Demireva
Andrew A. Kanner
Susan Pannullo
Maximilian Mehdorn
Nicholas Avgeropoulos
Andrea Salmaggi
Antonio Silvani
Samuel Goldlust
Carlos David
Alexandra Benouaich-Amiel
Journal of Neuro-Oncology, 2017, 135 : 545 - 552
[10] APPLICATION OF RTOG-RPA SCORES IN A PHASE 3 TRIAL OF TUMOR TREATING FIELDS WITH TEMOZOLOMIDE (TTFIELDS/TMZ) VERSUS TEMOZOLOMIDE (TMZ) ALONE IN NEWLY DIAGNOSED GLIOBLASTOMA
Choe, Kevin
Idbaih, Ahmed
Taillibert, Sophie
Escuder, Jordi Bruna
Sroubek, Jan
Kanner, Andrew
NEURO-ONCOLOGY, 2017, 19 : 8 - 9

← 1 2 3 4 5 →